SK3 Group, Inc. (OTC Pink: SKTO) today announces that it has appointed Jeffrey Benz, an experienced business attorney and former executive with various sports, entertainment, and technology companies, as General Counsel and Executive Vice President of Business, Legal, and Government Affairs.

"We are bringing together a management team with the unique and demonstrated abilities to drive our business to success," said Kevin Allyn, Chairman of SK3. "Jeff Benz has broad experience as a senior executive, lawyer, and entrepreneur in entertainment, sports, licensing, intellectual property, and technology. Jeff has been a trusted advisor to a variety of companies, both private and public, and has advised a number of high profile executives. Among other things, Mr. Benz was the General Counsel and head of business and government affairs for the United States Olympic Committee, AVP Pro Beach Volleyball Tour, and a variety of private companies in sports, entertainment (television, film, and online), and technology (mobile phone applications, computer software and hardware, and medical devices), and has lead high profile legal and operational functions in a wide array of industries, including internationally. Mr. Benz's extraordinary experience and background, and his legal leadership skills, uniquely fit our current needs and will lead SKTO into lucrative new markets."

Mr. Benz has BA and MBA degrees from the University of Michigan and a JD from the University of Texas. Mr. Benz is also an accomplished arbitrator and mediator, and has served as a private judge in, among other things, disputes over athlete doping issues in sports, having lead the anti-doping program at the USOC when he was there.

SK3 has shifted its business model to focus purely on the medical marijuana space. SK3 recently announced its acquisition of Medical Greens™, a business that currently provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens™ has already contracted over $30 Million in licensing and service agreements. As part of the company repositioning, the Board of Directors will be announcing new officers and executives throughout the next quarter. Besides his leadership role, Benz will be assisting with the recruitment, sourcing, and documenting relationships with key executives, directors, and strategic partners, including those for SK3's newly acquired subsidiary, Medical Greens™.

About SK3

SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Contact: A. Mayor info@medicalgreens.com

SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more SK3 (CE) Charts.
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more SK3 (CE) Charts.